Outcomes of Abrupt Switch to Bevacizumab of Patients Undergoing Aflibercept Intravitreal Injections for Neovascular Age-Related Macular Degeneration in a Tertiary Center in Lombardy, Italy: A Real-Life Retrospective Analysis.
Alessandro RandazzoRaffaele RaimondiGiovanni FossatiMary RomanoTania SorrentinoCarlo CastellaniCostanza RossiGiuseppe CancianPaolo VinciguerraPublished in: Journal of ophthalmology (2021)
Switching to bevacizumab has been safe and efficacious in patients responding to the loading phase. According to our results, the restrictions imposed by Lombardy Region did not cause any harm to patients undergoing intravitreal anti-VEGF injections.
Keyphrases
- age related macular degeneration
- patients undergoing
- end stage renal disease
- vascular endothelial growth factor
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- platelet rich plasma
- ultrasound guided
- metastatic colorectal cancer
- endothelial cells
- type diabetes
- metabolic syndrome
- skeletal muscle
- insulin resistance
- optical coherence tomography